ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
10.39
-0.19 (-1.80%)
At close: May 15, 2026, 4:00 PM EDT
10.50
+0.11 (1.06%)
After-hours: May 15, 2026, 4:10 PM EDT
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $93.17 million as of May 15, 2026. Its market cap has increased by 338.51% in one year.
Market Cap
93.17M
Enterprise Value
29.33M
1-Year Change
338.51%
Ranking
Category
Stock Price
$10.39
Market Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has increased from $21.82M to $93.17M, an increase of 326.98%. That is a compound annual growth rate of 10.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 93.17M | 534.25% |
| Dec 31, 2025 | 14.69M | -52.59% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 101.34M |
| Vivani Medical | 100.90M |
| Cibus | 99.93M |
| Aardvark Therapeutics | 99.70M |
| Oncolytics Biotech | 98.71M |
| Biomea Fusion | 97.60M |
| Seer, Inc. | 97.04M |
| Anixa Biosciences | 94.55M |